Antiplatelet therapy for recurrent stroke prevention: newer perspectives based on (MATCH), (CHARISMA), and (ESPRIT).

Abstract

Antiplatelet therapy is an important component of our armamentarium for recurrent stroke prevention. Aspirin is a safe and effective antiplatelet drug for recurrent stroke prevention, however, it has been challenged recently by the thienopyridine derivative, clopidogrel, and the combination agent, aspirin plus extended release dipyridamole. In this review, we discuss recent studies of thienopyridine derivatives and aspirin plus extended-release dipyridamole in stroke prevention and evidence-based guidelines for the administration of these agents in practice for recurrent stroke prevention.

• Authors: Philip B Gorelick
• Journal: Journal of the American Society of Hypertension : JASH (J Am Soc Hypertens) 2008 Jan-Feb Vol. 2 Issue 1 Pg. 3-7 ISSN: 1933-1711 [Print] United States
• PMID: 20409878 (Publication Type: Journal Article)